Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
- 31 May 1992
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 123 (5) , 1421-1425
- https://doi.org/10.1016/0002-8703(92)91064-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Safety and Tolerability of QuinaprilJournal of Cardiovascular Pharmacology, 1990
- Inhibition of Angiotensin-Converting Enzyme (ACE) in Plasma and TissueJournal of Cardiovascular Pharmacology, 1990
- Overview of Quinapril, A New ACE InhibitorJournal of Cardiovascular Pharmacology, 1990
- The Clinical Pharmacokinetics of QuinaprilAngiology, 1989
- ACCURACY OF THE TAKEDA TM‐2420 AMBULATORY BLOOD PRESSURE MONITORClinical and Experimental Pharmacology and Physiology, 1989
- Converting-Enzyme Inhibitors in the Treatment of HypertensionNew England Journal of Medicine, 1988
- Blood Pressure Monitoring for Assessing the Duration of Action of Antihypertensive TreatmentThe Journal of Clinical Pharmacology, 1987
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- Continuous Ambulatory Blood Pressure Monitoring Versus Casual Blood Pressure in Borderline HypertensionJournal of Cardiovascular Pharmacology, 1986
- Hemodynamic Changes During Sleep in Hypertensive PatientsCirculation, 1969